These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6733402)

  • 21. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of acromegaly by radioimmunoassay of somatomedin-C.
    Clemmons DR; Van Wyk JJ; Ridgway EC; Kliman B; Kjellberg RN; Underwood LE
    N Engl J Med; 1979 Nov; 301(21):1138-42. PubMed ID: 492275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
    Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
    Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromocriptine reduces growth hormone in acromegaly.
    Bell PM; Atkinson AB; Hadden DR; Kennedy L; Leslie H; Merrett JD; Sheridan B
    Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
    Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
    Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.
    Holdaway IM; Bolland MJ; Gamble GD
    Eur J Endocrinol; 2008 Aug; 159(2):89-95. PubMed ID: 18524797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of suppression of growth hormone levels following a 75g oral glucose tolerance test.
    Nazaimoon WM; Ng ML; Satgunasingam N; Khalid BA
    Med J Malaysia; 1992 Jun; 47(2):103-9. PubMed ID: 1494329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conventional supervoltage irradiation is an effective treatment for acromegaly.
    Eastman RC; Gorden P; Roth J
    J Clin Endocrinol Metab; 1979 Jun; 48(6):931-40. PubMed ID: 447799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasound measurements of overlying soft tissue thickness at four skeletal sites suitable for in vivo x-ray fluorescence.
    Pejović-Milić A; Brito JA; Gyorffy J; Chettle DR
    Med Phys; 2002 Nov; 29(11):2687-91. PubMed ID: 12462736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone values.
    Fogelman I; Hay ID; Citrin DL; Beastall GH; Turner JG; Bessent RG
    Br J Radiol; 1980 Sep; 53(633):874-7. PubMed ID: 7437709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiogrammetry of the soft tissue at the index finger in acromegaly.
    Dequeker J; Geussens P; De Proft G; Bouillon R
    Clin Radiol; 1979 Sep; 30(5):517-9. PubMed ID: 466955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GH response to oral and intravenous glucose load in acromegalic patients.
    Mancini A; Zuppi P; Fiumara C; Valle D; Conte G; Fabrizi ML; Sammartano L; Anile C; Maira G; De Marinis L
    Horm Metab Res; 1995 Jul; 27(7):322-5. PubMed ID: 7590615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery.
    Franks S; Jacobs HS; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):63-9. PubMed ID: 813917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy.
    Hartman ML; Veldhuis JD; Vance ML; Faria AC; Furlanetto RW; Thorner MO
    J Clin Endocrinol Metab; 1990 May; 70(5):1375-84. PubMed ID: 2335577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
    Freda PU; Nuruzzaman AT; Reyes CM; Sundeen RE; Post KD
    J Clin Endocrinol Metab; 2004 Feb; 89(2):495-500. PubMed ID: 14764751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility.
    Arafat AM; Müller L; Möhlig M; Mayr B; Kremenevskaya N; Pfeiffer AF; Buchfelder M; Schöfl C
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):685-91. PubMed ID: 21575028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of cryohypophysectomy in the treatment of acromegaly. Evaluation of 54 cases.
    DiTullio MV; Rand RW
    J Neurosurg; 1977 Jan; 46(1):1-11. PubMed ID: 830806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transsphenoidal subtotal hypophysectomy in the treatment of acromegaly.
    Bohmer T; Berdal P; Haugen HN
    Acta Endocrinol (Copenh); 1974 Nov; 77(3):477-84. PubMed ID: 4479318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.